• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-584 转染间充质干细胞衍生的外泌体:癌症治疗的新型治疗性载体。

Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy.

机构信息

Department of Biology Education, College of Education, Pusan National University, Busan 46241, Korea.

Department of Molecular Physiology, College of Pharmacy, Kyungpook National University, Daegu 41566, Korea.

出版信息

BMB Rep. 2018 Aug;51(8):406-411. doi: 10.5483/bmbrep.2018.51.8.105.

DOI:10.5483/bmbrep.2018.51.8.105
PMID:29966581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6130835/
Abstract

Exosomes are small membranous vesicles which contain abundant RNA molecules, and are transferred from releasing cells to uptaking cells. MicroRNA (miRNA) is one of the transferred molecules affecting the adopted cells, including glioma cells. We hypothesized that mesenchymal stem cells (MSCs) can secrete exosomes loading miRNA and have important effects on the progress of gliomas. To determine these effects by treating exosomal miRNA in culture media of miRNA mimic transfected MSCs, we assessed the in vitro cell proliferation and invasion capabilities, and the expression level of relative proteins associated with cell apoptosis, growth and migration. For animal studies, the mice injected with U87 cells were exposed to exosomes derived from miRNA-584-5p transfected MSCs, to confirm the influence of exosomal miRNA on the progress of glioma. Based on our results, we propose a new targeted cancer therapy wherein exosomes derived from miRNA transfected MSCs could be used to modulate tumor progress as the anticancer vehicles. [BMB Reports 2018; 51(8): 406-411].

摘要

外泌体是一种含有丰富 RNA 分子的小膜泡,从释放细胞转移到摄取细胞。微小 RNA(miRNA)是一种转移分子,可影响包括神经胶质瘤细胞在内的被摄取细胞。我们假设间充质干细胞(MSCs)可以分泌装载 miRNA 的外泌体,并对神经胶质瘤的进展有重要影响。为了通过在 miRNA 模拟转染 MSC 的培养介质中处理外泌体 miRNA 来确定这些影响,我们评估了体外细胞增殖和侵袭能力,以及与细胞凋亡、生长和迁移相关的相对蛋白的表达水平。在动物研究中,用 U87 细胞注射的小鼠暴露于源自 miRNA-584-5p 转染 MSC 的外泌体,以确认外泌体 miRNA 对神经胶质瘤进展的影响。基于我们的结果,我们提出了一种新的靶向癌症治疗方法,其中源自 miRNA 转染 MSC 的外泌体可作为抗癌载体用于调节肿瘤进展。[BMB 报告 2018;51(8):406-411]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/0b7eeac88dc0/bmb-51-406f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/f03637a9587d/bmb-51-406f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/e9c539c3b969/bmb-51-406f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/21ec3393080c/bmb-51-406f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/0b7eeac88dc0/bmb-51-406f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/f03637a9587d/bmb-51-406f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/e9c539c3b969/bmb-51-406f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/21ec3393080c/bmb-51-406f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892b/6130835/0b7eeac88dc0/bmb-51-406f4.jpg

相似文献

1
Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy.微小 RNA-584 转染间充质干细胞衍生的外泌体:癌症治疗的新型治疗性载体。
BMB Rep. 2018 Aug;51(8):406-411. doi: 10.5483/bmbrep.2018.51.8.105.
2
Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.间质干细胞衍生的外泌体 microRNA-133b 通过靶向 EZH2 抑制 Wnt/β-catenin 信号通路抑制神经胶质瘤进展。
Stem Cell Res Ther. 2019 Dec 16;10(1):381. doi: 10.1186/s13287-019-1446-z.
3
Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.源自过表达微小RNA-199a的间充质干细胞的外泌体通过下调AGAP2抑制胶质瘤进展。
Aging (Albany NY). 2019 Aug 5;11(15):5300-5318. doi: 10.18632/aging.102092.
4
hUC-MSCs secreted exosomes inhibit the glioma cell progression through PTENP1/miR-10a-5p/PTEN pathway.人脐带来源间充质干细胞分泌的外泌体通过 PTENP1/miR-10a-5p/PTEN 通路抑制神经胶质瘤细胞的进展。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):10013-10023. doi: 10.26355/eurrev_201911_19568.
5
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth.骨髓基质细胞来源的外泌体表达 miR-146b 抑制神经胶质瘤生长。
Cancer Lett. 2013 Jul 10;335(1):201-4. doi: 10.1016/j.canlet.2013.02.019. Epub 2013 Feb 16.
6
Human marrow stromal cells secrete microRNA-375-containing exosomes to regulate glioma progression.人骨髓基质细胞分泌含有 microRNA-375 的外泌体来调节神经胶质瘤的进展。
Cancer Gene Ther. 2020 Apr;27(3-4):203-215. doi: 10.1038/s41417-019-0079-9. Epub 2019 Feb 7.
7
Therapeutic Potential of Mesenchymal Cell-Derived miRNA-150-5p-Expressing Exosomes in Rheumatoid Arthritis Mediated by the Modulation of MMP14 and VEGF.间充质细胞衍生 miRNA-150-5p 表达外泌体通过调节 MMP14 和 VEGF 在类风湿关节炎中的治疗潜力。
J Immunol. 2018 Oct 15;201(8):2472-2482. doi: 10.4049/jimmunol.1800304. Epub 2018 Sep 17.
8
Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells.外泌体 miR-21a-5p 通过间充质干细胞介导心脏保护作用。
J Mol Cell Cardiol. 2018 Jun;119:125-137. doi: 10.1016/j.yjmcc.2018.04.012. Epub 2018 Apr 23.
9
Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.间充质干细胞将合成的微小RNA模拟物递送至胶质瘤细胞和胶质瘤干细胞,并抑制它们的细胞迁移和自我更新。
Oncotarget. 2013 Feb;4(2):346-61. doi: 10.18632/oncotarget.868.
10
Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer.骨髓间充质干细胞来源的外泌体 miRNA-1231 抑制胰腺癌的活性。
Cancer Med. 2019 Dec;8(18):7728-7740. doi: 10.1002/cam4.2633. Epub 2019 Oct 23.

引用本文的文献

1
Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment.探索两种肿瘤治疗策略:核糖体失活蛋白和间充质干细胞/MSC衍生的细胞外囊泡在癌症治疗中的有效性。
Front Oncol. 2025 May 13;15:1533065. doi: 10.3389/fonc.2025.1533065. eCollection 2025.
2
MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance.间充质干细胞衍生的细胞外囊泡:用于克服癌症治疗耐药性的精准miRNA递送
Regen Ther. 2025 Apr 1;29:303-318. doi: 10.1016/j.reth.2025.03.006. eCollection 2025 Jun.
3
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.

本文引用的文献

1
Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells.纤连蛋白表达在他莫昔芬耐药乳腺癌细胞中被 PI-3K/Akt 激活上调。
BMB Rep. 2017 Dec;50(12):615-620. doi: 10.5483/bmbrep.2017.50.12.096.
2
RETRACTED ARTICLE: MiR-124 Functions as a Tumor Suppressor via Targeting hCLOCK1 in Glioblastoma.撤回文章:微小RNA-124通过靶向胶质母细胞瘤中的hCLOCK1发挥肿瘤抑制作用。
Mol Neurobiol. 2017 Apr;54(3):2375. doi: 10.1007/s12035-016-9837-y. Epub 2016 Mar 11.
3
Emerging roles of exosomes in cancer invasion and metastasis.
基于外泌体的微小RNA递送:用间充质干细胞改变癌症治疗
Regen Ther. 2025 Feb 13;28:558-572. doi: 10.1016/j.reth.2025.01.019. eCollection 2025 Mar.
4
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer.天然及生物工程细胞外囊泡在癌症诊断、监测与治疗中的应用
ACS Nano. 2025 Feb 18;19(6):5871-5896. doi: 10.1021/acsnano.4c11630. Epub 2025 Jan 27.
5
The Masquelet technique triggers the formation of a network involving LncRNA, circRNA, miRNA, and mRNA during bone repair.Masquelet 技术在骨修复过程中触发涉及长链非编码 RNA、环状 RNA、微小 RNA 和信使 RNA 的网络形成。
Ann Med. 2024 Dec;56(1):2395591. doi: 10.1080/07853890.2024.2395591. Epub 2024 Oct 23.
6
Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study.探索外泌体微小RNA在胶质瘤中的临床意义及应用:一项综合研究
Cancer Cell Int. 2024 Sep 27;24(1):323. doi: 10.1186/s12935-024-03507-x.
7
Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment.当前基于非金属纳米颗粒的胶质母细胞瘤治疗方法
Biomedicines. 2024 Aug 11;12(8):1822. doi: 10.3390/biomedicines12081822.
8
miRNA-Driven Regulation of Endothelial-to-Mesenchymal Transition Differs among Thoracic Aortic Aneurysms.miRNA 驱动的血管内皮细胞向间充质细胞转化的调控在胸主动脉瘤中存在差异。
Cells. 2024 Jul 25;13(15):1252. doi: 10.3390/cells13151252.
9
The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy.间充质干细胞来源的人工修饰外泌体在肿瘤治疗中的潜在应用。
Front Oncol. 2024 Jan 4;13:1299384. doi: 10.3389/fonc.2023.1299384. eCollection 2023.
10
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity.间质干细胞衍生的细胞外囊泡在癌症治疗抵抗中的作用:从生物学到临床机遇。
Int J Biol Sci. 2024 Jan 1;20(1):347-366. doi: 10.7150/ijbs.88500. eCollection 2024.
外泌体在癌症侵袭和转移中的新作用。
BMB Rep. 2016 Jan;49(1):18-25. doi: 10.5483/BMBRep.2016.49.1.239.
4
Securin promotes migration and invasion via matrix metalloproteinases in glioma cells.分离酶通过基质金属蛋白酶促进胶质瘤细胞的迁移和侵袭。
Oncol Lett. 2015 Jun;9(6):2895-2901. doi: 10.3892/ol.2015.3074. Epub 2015 Mar 26.
5
miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14.微小RNA-584-5p通过抑制基质金属蛋白酶14的转录在人类神经母细胞瘤中发挥肿瘤抑制功能。
Biochim Biophys Acta. 2015 Sep;1852(9):1743-54. doi: 10.1016/j.bbadis.2015.06.002. Epub 2015 Jun 3.
6
Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach.用于癌症治疗的肿瘤微环境调控:一种生物材料方法。
J Funct Biomater. 2015 Feb 17;6(1):81-103. doi: 10.3390/jfb6010081.
7
MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.微小RNA-584在胶质瘤中作为肿瘤抑制因子发挥作用,并靶向垂体肿瘤转化基因1相互作用蛋白(PTTG1IP)。
Int J Clin Exp Pathol. 2014 Dec 1;7(12):8573-82. eCollection 2014.
8
SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma.基质细胞衍生因子 1/CXCR4 轴通过上调生存素促进胶质母细胞瘤细胞周期进程和上皮-间充质转化。
Mol Neurobiol. 2016 Jan;53(1):210-215. doi: 10.1007/s12035-014-9006-0. Epub 2014 Nov 25.
9
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.来自骨髓间充质干细胞的外泌体含有一种促进转移性乳腺癌细胞休眠的微小核糖核酸。
Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.
10
Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro.来自人脂肪组织间充质干细胞和脐带间充质干细胞的条件培养基在体外能有效诱导人胶质瘤细胞系的凋亡和分化。
Biomed Res Int. 2014;2014:109389. doi: 10.1155/2014/109389. Epub 2014 May 27.